Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marais

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Cardiovascular Journal of Africa|November 21, 2019
Familial hypercholesterolaemia workshop for leveraging point-of-care testing and personalised medicine in association with the Lipid and Atherosclerosis Society of Southern AfricaA D Marais, M J Kotze, F J Raal, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 7, 2017
Residual allergenicity of amino acid-based and extensively hydrolysed cow's milk formulasM E Levin, D M Blackhurst, F Kirstein, et al.
Human Mutation|July 23, 2003
Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemiaA J Whitfield, A D Marais, K Robertson, et al.
Journal of Lipid Research|November 1, 1992
Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian originD C Rubinsztein, G A Coetzee, A D Marais, et al.
AJNR. American Journal of Neuroradiology|October 27, 2022
Malignant Melanotic Nerve Sheath TumorJ C Benson, M D Marais, P M Flanigan, et al.
The Biochemical Journal|August 1, 1991
Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradationD R van der Westhuyzen, M L Stein, H E Henderson, et al.
Atherosclerosis|August 23, 1996
Two novel point mutations causing receptor-negative familial hypercholesterolemia in a South African Indian homozygoteE Langenhoven, L Warnich, R Thiart, et al.
Cardiovascular Drugs and Therapy|April 1, 1989
Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatinG M Berger, A D Marais, H C Seftel, et al.
Journal of Gastroenterology and Hepatology|May 19, 2006
Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiencyRichard Kirsch, Vivian Clarkson, Robert C Verdonk, et al.
Atherosclerosis|January 26, 1996
Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemiaR P Naoumova, A D Marais, J Mountney, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Cardiovascular Journal of Africa|November 21, 2019
Familial hypercholesterolaemia workshop for leveraging point-of-care testing and personalised medicine in association with the Lipid and Atherosclerosis Society of Southern AfricaA D Marais, M J Kotze, F J Raal, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 7, 2017
Residual allergenicity of amino acid-based and extensively hydrolysed cow's milk formulasM E Levin, D M Blackhurst, F Kirstein, et al.
Human Mutation|July 23, 2003
Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemiaA J Whitfield, A D Marais, K Robertson, et al.
Journal of Lipid Research|November 1, 1992
Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian originD C Rubinsztein, G A Coetzee, A D Marais, et al.
AJNR. American Journal of Neuroradiology|October 27, 2022
Malignant Melanotic Nerve Sheath TumorJ C Benson, M D Marais, P M Flanigan, et al.
The Biochemical Journal|August 1, 1991
Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradationD R van der Westhuyzen, M L Stein, H E Henderson, et al.
Atherosclerosis|August 23, 1996
Two novel point mutations causing receptor-negative familial hypercholesterolemia in a South African Indian homozygoteE Langenhoven, L Warnich, R Thiart, et al.
Cardiovascular Drugs and Therapy|April 1, 1989
Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatinG M Berger, A D Marais, H C Seftel, et al.
Journal of Gastroenterology and Hepatology|May 19, 2006
Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiencyRichard Kirsch, Vivian Clarkson, Robert C Verdonk, et al.
Atherosclerosis|January 26, 1996
Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemiaR P Naoumova, A D Marais, J Mountney, et al.
Pageof 11